HDACi as potential therapeutic avenue to promote dormancy. »
12/02/20

Upregulation of FATP4, CD36 and ACSL1 might promote NMIBC progression. »
08/14/20

Survival analysis showed better prognosis in patients with lower IL-6 expression. »
04/07/21

Patients with low-risk scores treated with chemotherapy tended to have shorter overall survival. »
07/17/21

Total CTCs, pathology type, and CTC-WBC clusters can be used as prognostic indicators for MFS of RCC patients. »
07/17/21

rrDLBCL tumor samples have lower number of genes affected compared to dDLBCL tumor samples. »
07/18/21

Pan-HDAC inhibitor panobinostat exhibited potent anti-proliferative activity at low nanomolar concentrations. »
07/20/21

Sphingomyelin C16:1 and phosphatidylcholine C30:2 inversely associated with percent mammographic density. »
07/23/21

Several clinically-approved drugs targeting the GBM molecular signature identified . »
07/23/21

Important role of monocytes and macrophages in prostate cancer. »
07/22/21